Quantum announced that national television network CTV News’ flagship investigative program W5 has aired the final segment, Part Three, of their three-part series about Quantum Biopharma and the company’s allegations of stock market manipulation. CTV News journalist and W5 investigative reporter Jon Woodward provides highlights of Part Three of the series in an article entitled, “‘Market manipulation’ cases trending up in Canada; regulator data”. The series explores the phenomenon of “stock spoofing”, a market manipulation tactic that is illegal in Canada and the United States, and the basis of a $700M lawsuit by Quantum Biopharma against two of Canada’s largest banks, CIBC and RBC.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QNTM:
- Quantum BioPharma Alleges Stock Manipulation in $700M Lawsuit
- Quantum BioPharma’s Stock Manipulation Allegations Spotlighted by CTV’s W5
- Quantum BioPharma’s $700M Lawsuit Featured in CTV’s W5 Series
- QNTM Upcoming Earnings Report: What to Expect?
- Quantum BioPharma Reports Strong Q3 2025 Results and Advances MS Drug Trials